Cargando…

N1-Benzofused Modification of Fluoroquinolones Reduces Activity Against Gram-Negative Bacteria

[Image: see text] The fluoroquinolone class of antibiotics has a well-established structure–activity relationship (SAR) and a long history in the clinic, but the effect of electron-rich benzofused substituents at the N1 position remains poorly explored. Because groups at this position are part of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Laws, Mark, Hind, Charlotte, Favaron, Andrea, Jamshidi, Shirin, Evans, Bonnie, Clifford, Melanie, Sutton, J. Mark, Rahman, Khondaker Miraz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7271024/
https://www.ncbi.nlm.nih.gov/pubmed/32548371
http://dx.doi.org/10.1021/acsomega.9b03910
_version_ 1783542010446086144
author Laws, Mark
Hind, Charlotte
Favaron, Andrea
Jamshidi, Shirin
Evans, Bonnie
Clifford, Melanie
Sutton, J. Mark
Rahman, Khondaker Miraz
author_facet Laws, Mark
Hind, Charlotte
Favaron, Andrea
Jamshidi, Shirin
Evans, Bonnie
Clifford, Melanie
Sutton, J. Mark
Rahman, Khondaker Miraz
author_sort Laws, Mark
collection PubMed
description [Image: see text] The fluoroquinolone class of antibiotics has a well-established structure–activity relationship (SAR) and a long history in the clinic, but the effect of electron-rich benzofused substituents at the N1 position remains poorly explored. Because groups at this position are part of the topoisomerase–DNA binding complex and form a hydrophobic interaction with the major groove of DNA, it was hypothesized that an electron-rich benzofused N1 substituent could enhance this interaction. Molecular modeling techniques were employed to evaluate the binding of certain N1-modified fluoroquinolones to DNA gyrase targets from both Staphylococcus aureus and Klebsiella pneumoniae species compared with ciprofloxacin and norfloxacin. Seven N1-modified fluoroquinolones were subsequently synthesized and tested against a panel of Gram-negative pathogens to determine minimum inhibitory concentration (MIC) values. Gram-negative outer membrane penetration was investigated using the membrane permeabilizer polymyxin B nonapeptide and compound efflux via resistance–nodulation–division-family efflux transporters was evaluated using the known efflux pump inhibitor phenylalanine–arginine β-naphthylamide. Additionally, the target inhibitory activity of representative compound 6e was determined in a cell-free environment. A correlation between N1 substituent hydrophobicity and activity was observed across the MIC panel, with compound activity decreasing with increased hydrophobicity. Those compounds with highest hydrophobicity were inactive because of poor solubility profiles whereas compounds with intermediate hydrophobicity were inactive because of impaired outer membrane penetration, and reduced inhibition of topoisomerase targets, the latter in contrast to modeling predictions. This study adds new information to the fluoroquinolone SAR and suggests limited utility of large hydrophobic substituents at the N1 position of fluoroquinolones.
format Online
Article
Text
id pubmed-7271024
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-72710242020-06-15 N1-Benzofused Modification of Fluoroquinolones Reduces Activity Against Gram-Negative Bacteria Laws, Mark Hind, Charlotte Favaron, Andrea Jamshidi, Shirin Evans, Bonnie Clifford, Melanie Sutton, J. Mark Rahman, Khondaker Miraz ACS Omega [Image: see text] The fluoroquinolone class of antibiotics has a well-established structure–activity relationship (SAR) and a long history in the clinic, but the effect of electron-rich benzofused substituents at the N1 position remains poorly explored. Because groups at this position are part of the topoisomerase–DNA binding complex and form a hydrophobic interaction with the major groove of DNA, it was hypothesized that an electron-rich benzofused N1 substituent could enhance this interaction. Molecular modeling techniques were employed to evaluate the binding of certain N1-modified fluoroquinolones to DNA gyrase targets from both Staphylococcus aureus and Klebsiella pneumoniae species compared with ciprofloxacin and norfloxacin. Seven N1-modified fluoroquinolones were subsequently synthesized and tested against a panel of Gram-negative pathogens to determine minimum inhibitory concentration (MIC) values. Gram-negative outer membrane penetration was investigated using the membrane permeabilizer polymyxin B nonapeptide and compound efflux via resistance–nodulation–division-family efflux transporters was evaluated using the known efflux pump inhibitor phenylalanine–arginine β-naphthylamide. Additionally, the target inhibitory activity of representative compound 6e was determined in a cell-free environment. A correlation between N1 substituent hydrophobicity and activity was observed across the MIC panel, with compound activity decreasing with increased hydrophobicity. Those compounds with highest hydrophobicity were inactive because of poor solubility profiles whereas compounds with intermediate hydrophobicity were inactive because of impaired outer membrane penetration, and reduced inhibition of topoisomerase targets, the latter in contrast to modeling predictions. This study adds new information to the fluoroquinolone SAR and suggests limited utility of large hydrophobic substituents at the N1 position of fluoroquinolones. American Chemical Society 2020-05-18 /pmc/articles/PMC7271024/ /pubmed/32548371 http://dx.doi.org/10.1021/acsomega.9b03910 Text en Copyright © 2020 American Chemical Society This is an open access article published under a Creative Commons Attribution (CC-BY) License (http://pubs.acs.org/page/policy/authorchoice_ccby_termsofuse.html) , which permits unrestricted use, distribution and reproduction in any medium, provided the author and source are cited.
spellingShingle Laws, Mark
Hind, Charlotte
Favaron, Andrea
Jamshidi, Shirin
Evans, Bonnie
Clifford, Melanie
Sutton, J. Mark
Rahman, Khondaker Miraz
N1-Benzofused Modification of Fluoroquinolones Reduces Activity Against Gram-Negative Bacteria
title N1-Benzofused Modification of Fluoroquinolones Reduces Activity Against Gram-Negative Bacteria
title_full N1-Benzofused Modification of Fluoroquinolones Reduces Activity Against Gram-Negative Bacteria
title_fullStr N1-Benzofused Modification of Fluoroquinolones Reduces Activity Against Gram-Negative Bacteria
title_full_unstemmed N1-Benzofused Modification of Fluoroquinolones Reduces Activity Against Gram-Negative Bacteria
title_short N1-Benzofused Modification of Fluoroquinolones Reduces Activity Against Gram-Negative Bacteria
title_sort n1-benzofused modification of fluoroquinolones reduces activity against gram-negative bacteria
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7271024/
https://www.ncbi.nlm.nih.gov/pubmed/32548371
http://dx.doi.org/10.1021/acsomega.9b03910
work_keys_str_mv AT lawsmark n1benzofusedmodificationoffluoroquinolonesreducesactivityagainstgramnegativebacteria
AT hindcharlotte n1benzofusedmodificationoffluoroquinolonesreducesactivityagainstgramnegativebacteria
AT favaronandrea n1benzofusedmodificationoffluoroquinolonesreducesactivityagainstgramnegativebacteria
AT jamshidishirin n1benzofusedmodificationoffluoroquinolonesreducesactivityagainstgramnegativebacteria
AT evansbonnie n1benzofusedmodificationoffluoroquinolonesreducesactivityagainstgramnegativebacteria
AT cliffordmelanie n1benzofusedmodificationoffluoroquinolonesreducesactivityagainstgramnegativebacteria
AT suttonjmark n1benzofusedmodificationoffluoroquinolonesreducesactivityagainstgramnegativebacteria
AT rahmankhondakermiraz n1benzofusedmodificationoffluoroquinolonesreducesactivityagainstgramnegativebacteria